Efficacy of PI3K inhibitors to PI3K mutants in enzyme and cell levels

被引：0
|
作者：
Dan, Shingo [1 ]
Sugita, Hironobu [1 ]
Yamazaki, Kanami [1 ]
Yamori, Takao [1 ]
机构：
[1] Japanese Fdn Canc Res, Tokyo, Japan
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-214
引用
收藏
页数：1
相关论文
共 50 条
  • [31] The PI3K/AKT/MTOR signaling pathway: The role of PI3K and AKT inhibitors in breast cancer
    Huemer F.
    Bartsch R.
    Gnant M.
    Current Breast Cancer Reports, 2014, 6 (2) : 59 - 70
  • [32] Biomarker evaluation in phase I clinical trials of selective PI3K and PI3k/mTOR inhibitors
    Spoerke, Jill
    Desai, Rupal
    Patel, Rajesh
    Fredrickson, Jill
    Wang, Yulei
    Levy, Gallia
    Gendreau, Steve
    Lauchle, Jennifer
    Derynck, Mika
    Raja, Rajiv
    Koeppen, Hartmut
    Hampton, Garret
    Yan, Yibing
    Lackner, Mark R.
    CANCER RESEARCH, 2013, 73 (08)
  • [33] Biomarker evaluation In phase I clinical trials of selective PI3K and PI3K/mTOR inhibitors
    Spoerke, Jill
    O'Brien, Carol
    Wu, Jenny
    Desai, Rupal
    Patel, Rajesh
    Raja, Rajiv
    Koeppen, Hartmut
    Amler, Lukas
    Hampton, Garret
    Yan, Yibing
    Lackner, Mark R.
    CANCER RESEARCH, 2012, 72
  • [34] Activation of PI3K/Akt/mTOR Pathway and Dual Inhibitors of PI3K and mTOR in Endometrial Cancer
    Chen, Jiezhong
    Zhao, Kong-Nan
    Li, Rui
    Shao, Renfu
    Chen, Chen
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (26) : 3070 - 3080
  • [35] Suppression of insulin feedback enhances the efficacy of PI3K inhibitors
    Hopkins, Benjamin D.
    Pauli, Chantal
    Xing, Du
    Wang, Diana G.
    Li, Xiang
    Wu, David
    Amadiume, Solomon C.
    Goncalves, Marcus D.
    Hodakoski, Cindy
    Lundquist, Mark R.
    Bareja, Rohan
    Ma, Yan
    Harris, Emily M.
    Sboner, Andrea
    Beltran, Himisha
    Rubin, Mark A.
    Mukherjee, Siddhartha
    Cantley, Lewis C.
    NATURE, 2018, 560 (7719) : 499 - +
  • [36] Suppression of insulin feedback enhances the efficacy of PI3K inhibitors
    Benjamin D. Hopkins
    Chantal Pauli
    Xing Du
    Diana G. Wang
    Xiang Li
    David Wu
    Solomon C. Amadiume
    Marcus D. Goncalves
    Cindy Hodakoski
    Mark R. Lundquist
    Rohan Bareja
    Yan Ma
    Emily M. Harris
    Andrea Sboner
    Himisha Beltran
    Mark A. Rubin
    Siddhartha Mukherjee
    Lewis C. Cantley
    Nature, 2018, 560 : 499 - 503
  • [37] Targeting PI3K
    Cantley, L.
    Lewis, C. Cantley
    CANCER RESEARCH, 2012, 72
  • [38] Role of PI3Kδ and PI3Kγ in inflammatory arthritis and tissue localization of neutrophils
    Randis, Tara M.
    Puri, Kamal D.
    Zhou, Hairu
    Diacovo, Thomas G.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2008, 38 (05) : 1215 - 1224
  • [39] PI3Kδ and PI3Kγ: partners in crime in inflammation in rheumatoid arthritis and beyond?
    Christian Rommel
    Montserrat Camps
    Hong Ji
    Nature Reviews Immunology, 2007, 7 : 191 - 201
  • [40] Attenuating PI3K isoforms in pancreatic cancer: Focus on immune PI3Kγ
    Basset, C.
    Guillermet-Guibert, J.
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2017, 41 (04) : 351 - 353
12345